Search
Sabra Health Care REIT Inc
SBRAAdd to Watchlist
19.510USD
-0.010-0.05%
Close 06/30, 16:00（ET）Quotes delayed by 15 min
4.92BMarket Cap
30.60P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-30The current earnings forecast score of Sabra Health Care REIT Inc is 7.29, ranking 74 out of 191 in the Residential & Commercial REITs industry. The average price target is 21.00, with a high of 22.00 and a low of 20.00.
Analyst Rating
Based on
15
analysts
Hold
Current Rating
22.000
Target Price
+12.70%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
92
Total
8
Median
10
Average
Company name
Ratings
Analysts
Sabra Health Care REIT Inc
SBRA
15
Digital Realty Trust Inc
DLR
33
Equinix Inc
EQIX
33
American Tower Corp
AMT
25
VICI Properties Inc
VICI
25
Gaming and Leisure Properties Inc
GLPI
24
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Sabra Health Care REIT Inc's expected revenue for the next quarter?
Sabra Health Care REIT Inc's expected revenue is 217.24M.
What is Sabra Health Care REIT Inc's price target?
Analysts forecast that Sabra Health Care REIT Inc's price target is USD 21.00, with the highest forecast at USD 22.00 and the lowest forecast at USD 20.00.
How have Sabra Health Care REIT IncSBRA's recent earnings per share performed?
The market expectation was USD 0.16, while Sabra Health Care REIT IncSBRA's earnings per share (EPS) for the previous quarter was USD 0.11. EPS for the next quarter is expected at USD 0.17.
What is the analyst rating for Sabra Health Care REIT Inc?
Based on the ratings of Sabra Health Care REIT Inc's stock from 15 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
